Effect of initial nitric oxide concentration on outcome in infants with persistent pulmonary hypertension of the newborn

Biology of the Neonate

Volumn 75, Issue 4, 1999, Pages 215-224

  Wood, Karen S ^a   McCaffrey, Martin J ^a   Donovan, Jocelyn C ^a   Stiles, Alan D ^a   Bose, Carl L ^a  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

Dosing regimen; Extracorporeal membrane oxygenation; Inhaled nitric oxide; Neonates; Persistent pulmonary hypertension, outcome

Indexed keywords

NITRIC OXIDE; VASODILATOR AGENT;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; MORTALITY; NEWBORN; OXYGENATION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0033065345     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014098     Document Type: Article

References (35)

1. Abman SH, Chatfield BA, Hall SL, McMurty IF: Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 1990;259: H1921-H1927.
2. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM: Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-2047.
3. Moncada S, Higgs EA: Endogenous nitric oxide: Physiology, pathology and clinical relevance, Eur J Clin Invest 1991;21:361-374.
4. Roberts JD, Chen T, Kawai N, Wain J, Dupuy P, Shimouchi A, Bloch K, Polaner D, Zapol WM: Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ Res 1993;72:246-254.
5. Zayek M, Cleveland D, Morin DC III: Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. J Pediatr 1993;122:743-750.
6. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
7. Roberts JD, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM: Inhaled nitric oxide in congenital heart disease. Circulation 1993;87:447-453.
8. Roberts JD, Polaner DM, Lang P, Zapol WM: Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340: 818-819.
9. Kinsella JP, Neish SR, Shaffer E, Abman SH: Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:819-820.
10. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH: Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr 1993; 123:103-108.
11. Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA: Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: Dose response. J Pediatr 1994;124:302-308.
12. Skimming JW, Bender KA, Hutchison AA, Drummond WH: Nitric oxide inhalation in infants with respiratory distress syndrome. J Pediatr 1997;130:225-230.
13. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R: New Ballard score expanded to include extremely premature infants. J Pediatr 1991;119:417-423.
14. Goldman AP, Tasker RC, Haworth SG, Sigston PE, Macrae DJ: Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 1996;98:706-713.
15. Hugod C: Effect of exposure to 43 ppm nitric oxide and 3.6 ppm nitrogen dioxide on rabbit lung. Int Arch Occup Environ Health 1979;42: 159-167.
16. Shiel FO: Morbid anatomical changes in the lungs of dogs after inhalation of higher oxides of nitrogen during anaesthesia. Br J Anaesth 1967;39:413-424.
17. Greenbaum R, Bay J, Hargreaves MD, Kain ML, Kelman GR, Nunn JF, Prys-Roberts C, Siebold K: Effects of higher oxides of nitrogen on the anaesthetized dog. Br J Anaesth 1967;39:393-404.
18. Roberts JD, Fineman JR, Morin FC III, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, Zapol WM: Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 1997; 336:605-610.
19. Neonatal Inhaled Nitric Oxide Study Group: Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604.
20. Barefield ES, Karle VA, Philips JB III, Carlo WA: Inhaled nitric oxide in term infants with hypoxemic respiratory failure. J Pediatr 1996; 129:279-286.
21. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, Redding GJ, de Lemos RA, Sardesai S, McCurnin DC, Moreland SG, Cutter GR, Abman SH: Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pcdiatr 1997;131: 55-62.
22. Mercier JC, Dehan M, Group Français Pédialrique d'Etude du NO Inhalé: Inhalational nitric oxide in persistent pulmonary hypertension of the newborn: Results of the French Multicenter Open Study (abstract). Am J Respir Crit Care Med 1994;149:545.
23. Etches PC, Finer NN, Barrington KJ, Graham AJ, Chan WK: Nitric oxide reverses acute hypoxic pulmonary hypertension in the newborn piglet. Pediatr Res 1994;35:15-19.
24. Gerlach H, Rossaint R, Pappert D, Falke KJ: Time-course and doseresponse of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993;23: 445-447.
25. Puybasset L, Rouby JJ, Mourgeon E, Stewart TE, Cluzel P, Arthaud M, Poete P, Bodin L, Korinek AM, Viars P: Inhaled nitric oxide in acute respiratory failure: Dose-response curves. Intensive Care Med 1994;20:319-327.
26. Oda H, Nogami H, Kusumoto S, Nakajima T, Kurata A: Lifetime exposure to 2.4 ppm nitric oxide in mice. Environ Res 1980;22:254-263.
27. Bigatello LM, Hurford WE, Kacmarek RM, Roberts JD, Zapol WM: Prolonged inhalation in low concentrations of nitric oxide in patients with severe adult respiratory syndrome: Effects on pulmonary hemodynamics and oxygenation. Anesthesiology 1994;80:761-770.
28. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
29. Wink DA, Kazimierz S, Kasprzak CM, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Kock WH, Andrews AW, Allen JS, Keefer LK: DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991; 254:1001-1003.
30. Radi R, Beckman JS, Bush KM, Freeman BA: Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of Superoxide and nitric oxide. Arch Biochem Biophys 1991;288:481-487.
31. Gaston B, Drazen JM, Loscalzo J, Stamler JS: The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994;149:538-551.
32. Yoshida K, Kasama K: Biotransformation of nitric oxide. Environ Health Perspect 1987;73:201-206.
33. Gibson QH, Roughton FJW: The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin. J Physiol (Lond) 1957;136:507-526.
34. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J: Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 1991;338:1173-1174.
35. Kinsella JP, Toews WH, Henry D, Abman SH: Selective and sustained pulmonary vasodilation with inhalational nitric oxide therapy in a child with idiopathic pulmonary hypertension. J Pediatr 1993;122:803-806.